menu
    • menu

    Company profile for Extrovis AG

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    SERVICES

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Extrovis is a global pharmaceutical company based in Switzerland with subsidiaries in Hungary and India. The Indian unit employs 60 scientists and researchers focused on developing complex APIs and finished dosage forms for pharmaceutical products. The company has established a presence in Hungary to support its plans for entering the European market and employs a team for supply chain, regulatory, pharmacovigilance and custom...
    Extrovis is a global pharmaceutical company based in Switzerland with subsidiaries in Hungary and India. The Indian unit employs 60 scientists and researchers focused on developing complex APIs and finished dosage forms for pharmaceutical products. The company has established a presence in Hungary to support its plans for entering the European market and employs a team for supply chain, regulatory, pharmacovigilance and customer service. Extrovis' portfolio includes niche generic products, products with formulation improvements, and redesigned products for patient safety and convenience, mostly as drug-device combinations.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Extrovis AGSwitzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    Bahnhof-Park 4, Baar 6340
    Telephone
    Telephone
    +41 799697055
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.extrovis.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/extrovis-pvt-ltd
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Extrovis & Dr Reddy’s launch Generic Fluorouracil Cream
    Extrovis & Dr Reddy’s launch Generic Fluorouracil Cream

    21 Aug 2025

    // PRESS RELEASE

    https://www.expresspharma.in/extrovis-ag-and-dr-reddys-launch-authorised-generic-fluorouracil-cream-0-5-per-cent-in-us-market/

    PRESS RELEASE
    21 Aug 2025
    Share Share
    Extrovis' Sugammadex Receives Approval in Europe
    Extrovis' Sugammadex Receives Approval in Europe

    16 Jun 2023

    // EMA

    https://www.ema.europa.eu/en/documents/overview/sugammadex-adroiq-epar-medicine-overview_en.pdf

    EMA
    16 Jun 2023
    Share Share
    Extrovis' Lacosamide Adroiq (lacosamide) Receives Approval in Europe
    Extrovis' Lacosamide Adroiq (lacosamide) Receives Approval in Europe

    05 Jun 2023

    // EMA

    https://www.ema.europa.eu/en/documents/overview/lacosamide-adroiq-epar-medicine-overview_en.pdf

    EMA
    05 Jun 2023
    Share Share
    Megasoft completed the acquisition of 40% stake in Extrovis AG.
    Megasoft completed the acquisition of 40% stake in Extrovis AG.

    19 Jan 2023

    // MARKET SCREENER

    https://www.marketscreener.com/quote/stock/MEGASOFT-LIMITED-6498580/news/Megasoft-Limited-completed-the-acquisition-of-40-stake-in-Extrovis-AG-42781952/

    MARKET SCREENER
    19 Jan 2023
    Share Share
    Megasoft Limited agreed to acquire 40% stake in EXTROVIS AG for $16 million.
    Megasoft Limited agreed to acquire 40% stake in EXTROVIS AG for $16 million.

    15 May 2022

    // MARKETSCREENER

    https://www.marketscreener.com/quote/stock/MEGASOFT-LIMITED-6498580/news/Megasoft-Limited-agreed-to-acquire-40-stake-in-EXTROVIS-AG-for-16-million-40454341/

    MARKETSCREENER
    15 May 2022
    Share Share

    ALL APIs

    read-moreClick the button for full data set
    read-moreClick the button for full data set

    01

    Dapsone

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    DDL Conference
    Not Confirmed
    arrow

    Dapsone

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    DDL Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down Click Us! arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 33630

    Submission : 2019-03-09

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2022-379 - Rev 00

    Issue Date : 2024-06-12

    Type : Chemical

    Substance Number : 77

    Status : Valid

     JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Calcium Gluconate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    DDL Conference
    Not Confirmed
    arrow

    Calcium Gluconate

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    DDL Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2023-10-24

    Pay. Date : 2023-10-03

    DMF Number : 37213

    Submission : 2023-07-05

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Eltrombopag

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    DDL Conference
    Not Confirmed
    arrow

    Eltrombopag

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    DDL Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 37907

    Submission : 2023-03-29

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Potassium Dihydrogen Phosphate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    DDL Conference
    Not Confirmed
    arrow

    Potassium Dihydrogen Phosphate

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    DDL Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2025-03-28

    Pay. Date : 2025-03-07

    DMF Number : 38689

    Submission : 2023-08-08

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Potassium Phosphate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    DDL Conference
    Not Confirmed
    arrow

    Potassium Phosphate

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    DDL Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2025-04-04

    Pay. Date : 2025-03-07

    DMF Number : 38688

    Submission : 2023-08-04

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Tolvaptan

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    DDL Conference
    Not Confirmed
    arrow

    Tolvaptan

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    DDL Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 34316

    Submission : 2020-01-22

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Trabectedin

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    DDL Conference
    Not Confirmed
    arrow

    Trabectedin

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    DDL Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 39511

    Submission : 2024-02-09

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Sugammadex Sodium

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    DDL Conference
    Not Confirmed
    arrow

    Sugammadex Sodium

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    DDL Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 35193

    Submission : 2020-12-22

    Status : Inactive

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Drugs in Development

    read-more
    read-more
    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Extrovis, Dr Reddy’s Launch Generic Fluorouracil Cream 0.5% In U.S.

    Details:

    Fluorouracil inhibits fungal DNA and RNA synthesis, is indicated for the topical treatment of multiple actinic or solar keratoses of the face and anterior scalp.


    Lead Product(s): Fluorouracil,Inapplicable

    Therapeutic Area: Dermatology Brand Name: Carac-Generic

    Study Phase: Approved FDFProduct Type: Cytotoxic Drug

    Sponsor: Dr. Reddy\'s Laboratories

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable August 20, 2025

    blank

    01

    Extrovis AG

    Switzerland
    arrow
    DDL Conference
    Not Confirmed

    Extrovis AG

    Switzerland
    arrow
    DDL Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Fluorouracil,Inapplicable

    Therapeutic Area : Dermatology

    Highest Development Status : Approved FDF

    Partner/Sponsor/Collaborator : Dr. Reddy\'s Laboratories

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Extrovis, Dr Reddy’s Launch Generic Fluorouracil Cream 0.5% In U.S.

    Details : Fluorouracil inhibits fungal DNA and RNA synthesis, is indicated for the topical treatment of multiple actinic or solar keratoses of the face and anterior scalp.

    Product Name : Carac-Generic

    Product Type : Cytotoxic Drug

    Upfront Cash : Inapplicable

    August 20, 2025

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    FDF Dossiers

    read-more
    read-more

    01

    Brand Name : AZITHROMYCIN

    Switzerland
    Antibody Engineering
    Not Confirmed
    arrow

    Brand Name : AZITHROMYCIN

    Switzerland
    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : DISCN

    Registration Country : USA

    AZITHROMYCIN

    Extrovis AG

    Dosage Form : TABLET;ORAL

    Brand Name : AZITHROMYCIN

    Dosage Strength : EQ 500MG BASE

    Packaging :

    Approval Date : 2007-05-30

    Application Number : 65366

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Brand Name : CALCIUM CHLORIDE 10%

    Switzerland
    Antibody Engineering
    Not Confirmed
    arrow

    Brand Name : CALCIUM CHLORIDE 10%

    Switzerland
    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : RX

    Registration Country : USA

    CALCIUM CHLORIDE

    Extrovis AG

    Dosage Form : INJECTABLE;INJECTION

    Brand Name : CALCIUM CHLORIDE 10%

    Dosage Strength : 100MG/ML

    Packaging :

    Approval Date : 2024-11-27

    Application Number : 219342

    Regulatory Info : RX

    Registration Country : USA

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Brand Name : CLINDAMYCIN PALMITAT...

    Switzerland
    Antibody Engineering
    Not Confirmed
    arrow

    Brand Name : CLINDAMYCIN PALMITAT...

    Switzerland
    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : DISCN

    Registration Country : USA

    CLINDAMYCIN PALMITATE HYDROCHLORIDE

    Extrovis AG

    Dosage Form : FOR SOLUTION;ORAL

    Brand Name : CLINDAMYCIN PALMITATE HYD...

    Dosage Strength : EQ 75MG BASE/5ML

    Packaging :

    Approval Date : 2016-05-25

    Application Number : 203063

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Brand Name : FLUDARABINE PHOSPHAT...

    Switzerland
    Antibody Engineering
    Not Confirmed
    arrow

    Brand Name : FLUDARABINE PHOSPHAT...

    Switzerland
    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : DISCN

    Registration Country : USA

    FLUDARABINE PHOSPHATE

    Extrovis AG

    Dosage Form : INJECTABLE;INJECTION

    Brand Name : FLUDARABINE PHOSPHATE

    Dosage Strength : 50MG/2ML (25MG/ML)

    Packaging :

    Approval Date : 2011-12-21

    Application Number : 200647

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Brand Name : EFUDEX

    Switzerland
    Antibody Engineering
    Not Confirmed
    arrow

    Brand Name : EFUDEX

    Switzerland
    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : RX

    Registration Country : USA

    FLUOROURACIL

    Extrovis AG

    Dosage Form : SOLUTION;TOPICAL

    Brand Name : EFUDEX

    Dosage Strength : 2%

    Packaging :

    Approval Date : 1982-01-01

    Application Number : 16831

    Regulatory Info : RX

    Registration Country : USA

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Brand Name : EFUDEX

    Switzerland
    Antibody Engineering
    Not Confirmed
    arrow

    Brand Name : EFUDEX

    Switzerland
    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : DISCN

    Registration Country : USA

    FLUOROURACIL

    Extrovis AG

    Dosage Form : SOLUTION;TOPICAL

    Brand Name : EFUDEX

    Dosage Strength : 5% **Federal Register ...

    Packaging :

    Approval Date : 1982-01-01

    Application Number : 16831

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Brand Name : EFUDEX

    Switzerland
    Antibody Engineering
    Not Confirmed
    arrow

    Brand Name : EFUDEX

    Switzerland
    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : RX

    Registration Country : USA

    FLUOROURACIL

    Extrovis AG

    Dosage Form : CREAM;TOPICAL

    Brand Name : EFUDEX

    Dosage Strength : 5%

    Packaging :

    Approval Date : 1982-01-01

    Application Number : 16831

    Regulatory Info : RX

    Registration Country : USA

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Brand Name : CARAC

    Switzerland
    Antibody Engineering
    Not Confirmed
    arrow

    Brand Name : CARAC

    Switzerland
    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : RX

    Registration Country : USA

    FLUOROURACIL

    Extrovis AG

    Dosage Form : CREAM;TOPICAL

    Brand Name : CARAC

    Dosage Strength : 0.5%

    Packaging :

    Approval Date : 2000-10-27

    Application Number : 20985

    Regulatory Info : RX

    Registration Country : USA

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Brand Name : FLUOROURACIL

    Switzerland
    Antibody Engineering
    Not Confirmed
    arrow

    Brand Name : FLUOROURACIL

    Switzerland
    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : DISCN

    Registration Country : USA

    FLUOROURACIL

    Extrovis AG

    Dosage Form : CREAM;TOPICAL

    Brand Name : FLUOROURACIL

    Dosage Strength : 0.5%

    Packaging :

    Approval Date : 2015-04-20

    Application Number : 203122

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Brand Name : IFOSFAMIDE

    Switzerland
    Antibody Engineering
    Not Confirmed
    arrow

    Brand Name : IFOSFAMIDE

    Switzerland
    arrow
    Antibody Engineering
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : DISCN

    Registration Country : USA

    IFOSFAMIDE

    Extrovis AG

    Dosage Form : INJECTABLE;INJECTION

    Brand Name : IFOSFAMIDE

    Dosage Strength : 1GM/20ML (50MG/ML)

    Packaging :

    Approval Date : 2012-11-26

    Application Number : 201689

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    FDA Orange Book

    read-more
    read-more

    Europe

    read-more
    read-more

    01

    Brand Name : Lacosamide Adroiq

    Switzerland
    DDL Conference
    Not Confirmed
    arrow

    Brand Name : Lacosamide Adroiq

    Switzerland
    arrow
    DDL Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Approved

    Registration Country : Sweden

    Lacosamide

    Extrovis AG

    Dosage Form : Infusion Solution

    Dosage Strength : 10mg/ml

    Packaging :

    Brand Name : Lacosamide Adroiq

    Approval Date : 31/05/2023

    Application Number : 20220401000278

    Regulatory Info : Approved

    Registration Country : Sweden

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Brand Name : Lacosamida Adroiq

    Switzerland
    DDL Conference
    Not Confirmed
    arrow

    Brand Name : Lacosamida Adroiq

    Switzerland
    arrow
    DDL Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Authorized

    Registration Country : Spain

    Lacosamide

    Extrovis AG

    Dosage Form : Solution For Perfusion

    Dosage Strength : 10MG

    Packaging :

    Brand Name : Lacosamida Adroiq

    Approval Date : 2023-11-22

    Application Number : 1231732001

    Regulatory Info : Authorized

    Registration Country : Spain

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Brand Name : Sugammadex Adroiq

    Switzerland
    DDL Conference
    Not Confirmed
    arrow

    Brand Name : Sugammadex Adroiq

    Switzerland
    arrow
    DDL Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Approved

    Registration Country : Sweden

    Sugammadex Sodium

    Extrovis AG

    Dosage Form : Injectable Solution

    Dosage Strength : 100mg/ml

    Packaging :

    Brand Name : Sugammadex Adroiq

    Approval Date : 26/05/2023

    Application Number : 20220401000261

    Regulatory Info : Approved

    Registration Country : Sweden

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Services

    Upload your portfolio for free, ask us

    API Manufacturing

    Click here to discover the service providers for API Manufacturing

    API & Drug Product Development

    Click here to discover the service providers for API & Drug Product Development

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Contact Extrovis AG and get a quotation

    Extrovis AG is a supplier offers 8 products (APIs, Excipients or Intermediates).

    Find a price of Dapsone bulk with DMF, CEP offered by Extrovis AG

    Find a price of Calcium Gluconate bulk with DMF offered by Extrovis AG

    Find a price of Eltrombopag bulk with DMF offered by Extrovis AG

    Find a price of Potassium Dihydrogen Phosphate bulk with DMF offered by Extrovis AG

    Find a price of Potassium Phosphate bulk with DMF offered by Extrovis AG

    Find a price of Tolvaptan bulk with DMF offered by Extrovis AG

    Find a price of Trabectedin bulk with DMF offered by Extrovis AG

    Find a price of Sugammadex Sodium bulk offered by Extrovis AG

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search